Top

Gepubliceerd in:

24-09-2015

Development of a measure of self-efficacy for acute headache medication adherence

Auteurs: Elizabeth K. Seng, Robert A. Nicholson, Kenneth A. Holroyd

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 6/2016

Abstract

Acute medication adherence is essential to manage chronic, episodic disorders, including headache. This paper describes the development of a measure of acute medication self-efficacy for headache (AMSE-H). Phase 1: 14 AMSE-H items were generated through qualitative interviews with 21 patients and 15 clinical headache experts. Phase 2: Researchers selected 7 AMSE-H items by examining item performance in 35 headache patients. Phase 3: Migraine patients (n = 161) completed the AMSE-H, and measures of outcome expectancies, perceived access to medication, headache management self-efficacy (n = 58) and a 1-week AMSE-H re-test (n = 103). Content validity was established through input of multiple stakeholder groups during item generation. PCA identified two components: cross-episode self-efficacy (eigenvalue = 3.4) and Episode-Specific Self-Efficacy (eigenvalue = 1.0). These subscales are internally consistent (.73–.80), have low 1-week test–retest reliability (rs = .52–.66), and demonstrated solid construct and discriminant validity. The AMSE-H is brief, theory-driven, focused, socially valid measure acceptable to both patients and providers.

vorige artikel A dyadic multiple mediation model of patient and spouse stressors predicting patient dietary and exercise adherence via depression symptoms and diabetes self-efficacy

volgende artikel Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis

Alleen toegankelijk voor geautoriseerde gebruikers

Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.CrossRefPubMed

Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W.H. Freeman.

Bandura, A. (2006). Guide for creating self-efficacy scales. In F. Pajares & T. Urdan (Eds.), Self-efficacy beliefs of adolescents. Greenwich, CT: Information Age Publication Inc.

Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., & Martelletti, P. (2012). Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS). The Journal of Headache and Pain, 13, 361–378.CrossRefPubMedPubMedCentral

Brantlinger, E., Jimenez, R., Klingner, J., Pugach, M., & Richardson, V. (2005). Qualitative studies in special education. Exceptional Children, 71, 195.CrossRef

Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations. Patient Education and Counseling, 36, 57–64.CrossRefPubMed

Burch, R. C., Loder, S., Loder, E., & Smitherman, T. A. (2015). The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache, 55, 21–34.CrossRefPubMed

Burkhart, P. V., & Sabate, E. (2003). Adherence to long-term therapies: Evidence for action. Journal of Nursing Scholarship, 35, 207.PubMed

Cady, R. K., Farmer, K., Beach, M. E., & Tarrasch, J. (2008). Nurse-based education: An office-based comparative model for education of migraine patients. Headache, 48, 564–569.CrossRefPubMed

DiMatteo, M. R. (2004). Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42, 200–209.CrossRefPubMed

Dunbar-Jacob, J., Erlen, J. A., Schlenk, E. A., Ryan, C. M., Sereika, S. M., & Doswell, W. M. (2000). Adherence in chronic disease. Annual Review of Nursing Research, 18, 48–90.PubMed

Ericsson, K. A., & Simon, H. A. (1993). Protocol analysis: Verbal reports as data (Revised Edition ed.). Cambridge, MA: The MIT Press.

Fernandez, S., Chaplin, W., Schoenthaler, A. M., & Ogedegbe, G. (2008). Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. Journal of Behavioral Medicine, 31, 453–462.CrossRefPubMedPubMedCentral

Foley, K., Cady, R., Martin, V., Adelman, J., Diamond, M., Bell, C., & Hu, X. (2005). Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache: The Journal of Head and Face Pain, 45, 538–545.CrossRef

Forsyth, A. D., & Carey, M. P. (1998). Measuring self-efficacy in the context of HIV risk reduction: Research challenges and recommendations. Health Psychology, 17, 559–568.CrossRefPubMed

French, D. J., Holroyd, K. A., Pinnell, C., Malinoski, P. T., ODonnell, F. J., & Hill, K. R. (2000). Perceived self-efficacy and headache-related disability. Headache, 40, 647–656.CrossRefPubMed

Gallagher, R., & Kunkel, R. (2003). Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache: The Journal of Head and Face Pain, 43, 36–43.CrossRef

Headache Classification Committee of the International Headache Society (IHS). (2013). The International classification of headache disorders, 3rd edition (beta version). Cephalalgia, 33, 629–808.CrossRef

Holroyd, K. A., Holm, J. F., Penzien, D. B., Cordingley, G. E., Hursey, K. G., Martin, N. J., & Theofanous, A. (1989). Long-term maintenance of improvements achieved with (abortive) pharmacological and nonpharmacological treatments for migraine: Preliminary findings. Biofeedback and Self Regulation, 14, 301–308.CrossRefPubMed

Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E., & Chesney, M. A. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project. AIDS Patient Care and STDs, 17, 645–656.CrossRefPubMed

Johnston, M. M., & Rapoport, A. M. (2010). Triptans for the management of migraine. Drugs, 70, 1505–1518.CrossRefPubMed

Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: Development of a pictographic visual analogue scale. Health Education Research, 20, 24–35.CrossRefPubMed

Katic, B. J., Krause, S. J., Tepper, S. J., Hu, H. X., & Bigal, M. E. (2010). Adherence to acute migraine medication: What does it mean, why does it matter? Headache, 50, 117–129.CrossRefPubMed

Lanteri-Minet, M., Duru, G., Mudge, M., & Cottrell, S. (2011). Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review. Cephalalgia, 31, 837–850.CrossRefPubMed

Lipton, R. B., Stewart, W. F., Sawyer, J., & Edmeads, J. (2001). Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) Questionnaire. Headache, 41, 854–861.CrossRefPubMed

Malik, S. N., Hopkins, M., Young, W. B., & Silberstein, S. D. (2006). Acute migraine treatment: Patterns of use and satisfaction in a clinical population. Headache, 46, 773–780.CrossRefPubMed

Marks, R., Allegrante, J., & Lorig, K. (2005). A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: Implications for health education practice. Health Promotion Practice, 6, 37–43.CrossRefPubMed

McLaughlin, G. (1969). SMOG grading: A new readability formula. Journal of Reading, 12, 639–646.

Miller, W., & Rollnick, S. (1991). Motivational interviewing: Preparing people for change. New York: Guilford Press.

Nicholson, R. A., Chibnall, J. T., Ng-Mak, D., Banks, J. W., & Smith, T. R. (2011a). Why wait? Reasons that patients delay taking a triptan during individual migraine attacks. Headache, 51, S6–S7.

Nicholson, R. A., Ng-Mak, D., Chibnall, J. T., Banks, J. W., & Smith, T. R. (2011). To use or not to use: Reasons for and consequences of not using a triptan during individual migraine attacks. Paper presented at the Annual Scientific Meeting of the American Headache Society, Washington, DC.

Nicholson, R. A., & Smith, T. R. (2015). Longtidunal real and near-time assessment of acute medication adherence during migraine attacks. Paper presented at the Annual Scientific Meeting of the American Headache Society, Washington, DC.

Nicholson, R. A., Smith, T. R., Banks, J. W., Chibnall, J. T., Holroyd, K. A., & Kreuter, M. K. (2010). Effectiveness of a tailored migraine management program. Paper presented at the European Headache and Migraine Trust International Congress, Nice, France.

Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill Inc.

Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. Journal of Clinical Epidemiology, 56, 520–529.CrossRefPubMed

Packard, R. C., & O’Connell, P. (1986). Medication compliance among headache patients. Headache, 26, 416–419.CrossRef

Peters, M., Abu-Saad, H. H., Vydelingum, V., Dowson, A., & Murphy, M. (2003). Patients’ decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia, 23, 833–841.CrossRefPubMed

Resnick, B., Wehren, L., & Orwig, D. (2003). Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales. Orthopaedic Nursing, 22, 139–147.CrossRefPubMed

Risser, J., Jacobson, T. A., & Kripalani, S. (2007). Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. Journal of Nursing Measurement, 15, 203–219.CrossRefPubMed

Rudy, B. J., Murphy, D. A., Harris, D. R., Muenz, L., & Ellen, J. (2009). Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: A study of prevalence and interactions. AIDS Patient Care and STDs, 23, 185–194.CrossRefPubMedPubMedCentral

Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39, 1151–1162.CrossRefPubMed

Schwartz, I., & Baer, D. (1991). Social validity assessments: Is current practice state of the art? Journal of Applied Behavior Analysis, 24, 16.

Seidman, I. (2006). Interviewing as qualitative research: A guide for researchers in education and the social sciences (3rd ed.). New York: Teachers College Press.

Seng, E. K., & Holroyd, K. A. (2013). Optimal use of acute headache medication: A qualitative examination of behaviors and barriers to their performance. Headache, 53, 1438–1450. doi:10.1111/head.12157 PubMed

Silberstein, S. (2000). Practice Parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Neurology, 55, 754–762.CrossRefPubMed

Turner, R. R., Quittner, A. L., Parasuraman, B. M., Kallich, J. D., & Cleeland, C. S. (2007). Patient-reported outcomes: Instrument development and selection issues. Value in Health, 10, S86–S93.CrossRefPubMed

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., & Memish, Z. A. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163–2196.CrossRefPubMed

Worthington, I., Pringsheim, T., Gawel, M. J., Gladstone, J., Cooper, P., Dilli, E., & Becker, W. J. (2013). Canadian Headache Society Guideline: Acute drug therapy for migraine headache. Canadian Journal of Neurological Sciences, 40, S1–S80.CrossRefPubMed

Titel: Development of a measure of self-efficacy for acute headache medication adherence
Auteurs: Elizabeth K. Seng
Robert A. Nicholson
Kenneth A. Holroyd
Publicatiedatum: 24-09-2015
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 6/2016
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-015-9683-9

Andere artikelen Uitgave 6/2016

Managing severe obesity: understanding and improving treatment adherence in bariatric surgery

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data

What do we know about mobile applications for diabetes self-management? A review of reviews

A dyadic multiple mediation model of patient and spouse stressors predicting patient dietary and exercise adherence via depression symptoms and diabetes self-efficacy

Bohn Stafleu van Loghum

Development of a measure of self-efficacy for acute headache medication adherence

Abstract

Andere artikelen Uitgave 6/2016

Managing severe obesity: understanding and improving treatment adherence in bariatric surgery

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data

What do we know about mobile applications for diabetes self-management? A review of reviews

A dyadic multiple mediation model of patient and spouse stressors predicting patient dietary and exercise adherence via depression symptoms and diabetes self-efficacy

Health care providers’ support of patients’ autonomy, phosphate medication adherence, race and gender in end stage renal disease

The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Managing severe obesity: understanding and improving treatment adherence in bariatric surgery

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data

What do we know about mobile applications for diabetes self-management? A review of reviews

A dyadic multiple mediation model of patient and spouse stressors predicting patient dietary and exercise adherence via depression symptoms and diabetes self-efficacy

Health care providers’ support of patients’ autonomy, phosphate medication adherence, race and gender in end stage renal disease

The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management